XRF Scientific Limited

ASX:XRF

XRF Scientific Limited

ASX:XRF
TradeAdd trade order Follow Unfollow Set Price Alert
$1.825 (-5.2%)
Last close price
#4
Rank
67
Held by
111
Followers
TradeAdd trade order Follow Unfollow Set Price Alert
Reports (19) My Report Forum Investors
Forum Topics XRF XRF ASX Announcements

Pinned straw:
mikebrisy
Added a month ago

Another small bolt-on acquistion by $XRF - this time combustion gas analysis instruments from a subsidiary of Bruker Corporation, at what looks like a reasonable price for what is a niche and likely quite mature business.

ASX Announcement

So I'm really focused on the strategic rationale: Why $XRF is a more logical owner than Bruker

The acquisition of the Combustion Gas Analysis (CGA) business from Bruker Corporation appears to be a classic case of a non-core divestment finding a more natural strategic home within $XRF. For Bruker, the CGA product line sits outside the core focus of its AXS division, which is centred on "high-end X-ray and advanced analytical technologies." The business is relatively small and oriented toward industrial quality control markets, making it subscale and strategically peripheral within a portfolio increasingly focused on higher-growth, higher-value applications. Divesting the asset allows Bruker to simplify its portfolio and redeploy capital toward more aligned opportunities. In summary, the business is immaterial to Bruker, and offloading it is a sensible rationalisation of a non-core asset.

For $XRF, however, the strategic fit is stronger. The CGA instruments extend XRF’s existing presence in elemental analysis and laboratory workflows, targeting the same customer base across mining, metals, cement and broader industrial sectors. This is not a step into an adjacent or unfamiliar market, but rather a logical expansion within the same analytical ecosystem. The ability to cross-sell CGA instruments alongside XRF’s existing products, and to introduce additional consumables revenue streams, is likely to increase the lifetime value of its customer relationships.

The transaction is about extending capability and product suite expansion rather than a pure growth acquisition. XRF is acquiring a technically credible but under-prioritised asset at a low entry multiple, with the opportunity to unlock value through better alignment, focus, distribution synergies and integration into its existing platform.

The strategic rationale rests on XRF’s ability to embed these products into its core offering and drive incremental revenue per customer, rather than relying on the standalone growth trajectory of the CGA business itself - which is probable a pretty mature business (but I don't know for sure).

Overall, it looks like a sensible acquisition at a good price.

Disc: Held
jcmleng
Added a month ago

Agreed @mikebrisy . This is another small XRF acquisition that makes good sense, with a lot to like. From the Brucker website:

dcc520a060b40094425a47545182fb469f058a.png

XRF and Brucker look like they have been in partnership for a long time. XRF will thus have full exposure to the acquired products in what looks like a very friendly sale from a long-term partner, virtually eliminating any risk related to the product itself and its fit into the XRF product portfolio.

It is highly consistent with the characteristics of XRF’s recent acqusitions of Labfit (Nov 2024), in that it:

  • Is another low risk, bolt-on acquisition with highly complementary products
  • Is a profitable product line
  • Expands XRF’s range of analytical instruments and enables cross-selling with existing products into existing customers
  • Enables expansion into new non-mining sectors as CGA revenue is dominated by those sectors - the Labfit acquisition opened up the water, beverage, environmental and agricultural sectors

1ed77428f207cd1a4d1630c676ce1e6bb01fed.png

  • Utilises XRF manfacturing capacity and capability
  • Adds new consumable revenue streams, required for the operation of the CGA products

XRF’s cash balance at 31 Dec 2025 was $12.1m, with $6.4m cash inflow from operations - funding the US$4m (~A$5.7m) should be a non-issue.

While the legal Asset Purchase Agreement will complete this week, it does appear that revenue flows only after transition of manufacturing to XRF in Perth, the “Completion” milestone on page 2, in 2QFY27.

27
Wini
Added a month ago

Nice summary @mikebrisy and @jcmleng.

Appears to be another sensible acquisition from XRF. There is no guarantee is works out but I do prefer to see acquisitions that are clearly strategic rather than financial. It's refreshing to see an announcement highlighting the operational synergies and strategic rationale rather than focusing on financial engineering to acquire scale or accretion.

41